Cocaine pharmacodynamics after intravenous and oral administration in rats: Relation to pharmacokinetics

Psychopharmacology

Volumn 144, Issue 4, 1999, Pages 323-332

  Ma, Fang ^a   Falk, John L ^a   Lau, Chyan E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Absolute oral bioavailability; Benzoylecgonine; Cocaine; Norcocaine; Pharmacod ynamics; Pharmacokinetics

Indexed keywords

COCAINE; NORCOCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG EFFECT; DRUG POTENCY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RESPONSE TIME;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; COCAINE; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; STREET DRUGS;

EID: 0032981914     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051014     Document Type: Article

References (46)

1. Allen CJ (1988) The hold life has: coca and cultural identity in an Andean community. Smithsonian Institution, Washington, D.C.
2. Barnett G, Hawks R, Resnick R (1981) Cocaine pharmacokinetics in humans. J Ethnopharmacol 3:353-366
3. Bedford JA, Borne RF, Wilson MC (1980) Comparative behavioral profile of cocaine and norcocaine in rats and monkeys. Pharmacol Biochem Behav 13:69-75
4. Benuck M, Lajtha A, Reith MEA (1987) Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243:144-149
5. Boni JP, Barr WH, Martin BR (1991) Cocaine inhalation in the rat: pharmacokinetics and cardiovascular response. J Pharmacol Exp Ther 257:307-315
6. Booze RM, Lehner AF, Wallace DR, Welch MA, Mactutus CF (1997) Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rate. Neurotoxicol Teratol 19:7-15
7. Cone EJ, Kumor K, Thompson LK, Sherer M (1988) Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J Anal Toxicol 12:200-206
8. Dawson GW, Jue SG, Brogden RN (1984) Alprazolam. Drugs 27:132-147
9. Dow-Edwards D, Fico TA, Osman M, Gamagaris Z, Hutchings DE (1989) Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacol Biochem Behav 33:167-173
10. Ellinwood EH Jr, Heatherly DG, Nkaido AM, Bjornsson TD, Kilts C (1985) Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychomacology 86:392-399
11. Evans SM, Cone EJ, Henningfield JE (1996) Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279:1345-1356
12. Falk JL, Ma F, Lau CE (1991) Chronic oral cocaine self-administration: pharmacokinetics and effects on spontaneous and discriminative motor functions. J Pharmacol Exp Ther 257:457-465
13. Farre M, Torre, RD, Llorente M, Lamas X, Ugena B, Segura J, Cami J (1993) Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 266:1364-1373
14. Fawcett JA, Kravitz HM (1982) Alprazolam. Pharmacotherapy 2:243-254
15. Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J (1977) Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatry 134:559-562
16. Hawks RL, Kopin IJ, Colburn RW, Thoa NB (1974) A pharmacologically active metabolite of cocaine found in brain. Life Sci 15:2189-2195
17. Inaba T (1989) Cocaine: pharmacokinetics and biotransformation in man. Can J Physiol Pharmacol 67:1154-1157
18. Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM (1978) Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 202:227-228
19. Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE (1989) Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 17:153-159
20. Johanson C, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52
21. Lamas X, Negus SS, Hall E, Mello NK (1995) Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys. Psychopharmacology 121:331-338
22. Lau CE, Heatherington AC (1997) Pharmacokinetic-pharmacodynamic modeling of stimulatory and sedative effects of alprazolam: timing performance deficits. J Pharmacol Exp Ther 283:1119-1129
23. Lau CE, Wang J (1996) Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. Psychopharmacology 126:115-124
24. Lau CE, Ma F, Falk JL (1990) Simultaneous determination of cocaine and its metabolites with caffeine in rat serum microsamples by high performance liquid chromatography. J Chromatogr 532:95-103
25. Lau CE, Imam A, Ma F, Falk JL (1991) Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J Pharmacol Exp Ther 257:444-456
26. Lau CE, Ma F, Wang Y, Smith C (1996) Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics. Psychopharmacology 126:241-248
27. Lau CE, Wang Y, Falk JL (1997a) Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. J Pharmacol Exp Ther 281:1013-1029
28. Lau CE, Wang Y, Falk JL (1997b) Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low rate (DRL 45-s) performance. Psychopharmacology 134:277-286
29. Lau CE, Wang Y, Ma F (1998) Pharmacokinetic-pharmacodynamic PD modeling of the coexistence of stimulatory and sedative components for midazolam. Eur J Pharmacol 346:131-144
30. Lau CE, Ma F, Falk JL (1999) Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits. J Pharmacol Exp Ther 288:535-543
31. Laurijssens BE, Greenblatt DJ (1996) Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 30:52-76
32. Ma F, Zhang J, Lau CE (1997) Determination of cocaine and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J Chromatogr B 693:307-312
33. Mandema JW, Tukker E, Danhof M (1991) Pharmacokinetic-pharmacodynamic modeling of the EEG effects of midazolam in individual rats: influence of rate and route of administration. Br J Pharmacol 102:663-668
34. 3H] benzoylecgonine and the pharmacological activity of some cocaine metabolites. J Pharm Pharmacol 27:784-786
35. 3H] cocaine in rat brain. Experientia (Basel) 30:1312-1314
36. 3H]cocaine in acutely and chronically treated rats. J Pharmacol Exp Ther 196:556-569
37. Pan W, Hedaya MA (1998) An animal model for simultaneous pharmacokinetic/pharmacodynamic investigations: application to cocaine. J Pharmacol Toxicol Methods 39:1-8
38. Ritchie JM, Cohen PJ (1975) Cocaine: procaine and other synthetic local anesthetics. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 379-403
39. 50 cocaine insult in a chronically instrumented rat model: are beta-blockers contraindicated? Ann Emerg Med 20:768-771
40. Van Dyke C, Jatlow P, Ungerer J, Barash PG, Byck R (1978) Oral cocaine: plasma concnetrations and central effects. Science 200:211-213
41. Wang Y, Lau CE (1998) Caffeine has similar pharmacokinetics and behavioral effects via the IP and PO routes of administration. Pharmacol Biochem Behav 60:271-278
42. Weiss B, Laties VC, Siegel L, Goldstein DA (1966) Computer analysis of serial interactions in spaced responding. J Exp Anal Behav 9:619-626
43. Wenger GR, Wright DW (1990) Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol Biochem Behav 35:595-600
44. Wilkinson P, Van Dyke C, Jatlow P, Barash P, Byck R (1980) Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27:386-394
45. Woolverton WL, Balster RL (1982) Behavioral pharmacology of local anesthetics: reinforcing and discriminative stimulus effects. Pharmacol Biochem Behav 16:491-500
46. Woolverton WL, Kandel D, Schuster CR (1978) Effects of repeated administration of cocaine on schedule-controlled behavior of rats. Pharmacol Biochem Behav 9:327-337